Literature DB >> 23174342

Inflammatory T helper 17 cells promote depression-like behavior in mice.

Eléonore Beurel1, Laurie E Harrington, Richard S Jope.   

Abstract

BACKGROUND: Recognition of substantial immune-neural interactions is revising dogmas about their insular actions and revealing that immune-neural interactions can substantially impact central nervous system functions. The inflammatory cytokine interleukin-6 promotes susceptibility to depression and drives production of inflammatory T helper 17 (Th17) T cells, raising the hypothesis that in mouse models, Th17 cells promote susceptibility to depression-like behaviors.
METHODS: Behavioral characteristics were measured in male mice administered Th17 cells, CD4(+) cells, or vehicle and in retinoid-related orphan receptor-γT (RORγT)(+/GFP) mice or male mice treated with RORγT inhibitor or anti-interleukin-17A antibodies.
RESULTS: Mouse brain Th17 cells were elevated by learned helplessness and chronic restraint stress, two common depression-like models. Th17 cell administration promoted learned helplessness in 89% of mice in a paradigm where no vehicle-treated mice developed learned helplessness, and impaired novelty suppressed feeding and social interaction behaviors. Mice deficient in the RORγT transcription factor necessary for Th17 cell production exhibited resistance to learned helplessness, identifying modulation of RORγT as a potential intervention. Treatment with the RORγT inhibitor SR1001, or anti-interleukin-17A antibodies to abrogate Th17 cell function, reduced Th17-dependent learned helplessness.
CONCLUSIONS: These findings indicate that Th17 cells are increased in the brain during depression-like states, promote depression-like behaviors in mice, and specifically inhibiting the production or function of Th17 cells reduces vulnerability to depression-like behavior, suggesting antidepressant effects may be attained by targeting Th17 cells.
Copyright © 2013 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23174342      PMCID: PMC3582833          DOI: 10.1016/j.biopsych.2012.09.021

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  52 in total

1.  Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells.

Authors:  Eléonore Beurel; Wen-I Yeh; Suzanne M Michalek; Laurie E Harrington; Richard S Jope
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

2.  A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.

Authors:  Catharine H Duman; Lee Schlesinger; Masafumi Kodama; David S Russell; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2006-08-30       Impact factor: 13.382

Review 3.  Animal models of neuropsychiatric disorders.

Authors:  Eric J Nestler; Steven E Hyman
Journal:  Nat Neurosci       Date:  2010-09-27       Impact factor: 24.884

Review 4.  Translational research in bipolar disorder: emerging insights from genetically based models.

Authors:  G Chen; I D Henter; H K Manji
Journal:  Mol Psychiatry       Date:  2010-02-09       Impact factor: 15.992

5.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

6.  Learned helplessness: validity and reliability of depressive-like states in mice.

Authors:  S Chourbaji; C Zacher; C Sanchis-Segura; C Dormann; B Vollmayr; P Gass
Journal:  Brain Res Brain Res Protoc       Date:  2005-11-23

7.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

8.  Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis.

Authors:  Zizhen Kang; Cengiz Zubeyir Altuntas; Muhammet Fatih Gulen; Caini Liu; Natalia Giltiay; Hongwei Qin; Liping Liu; Wen Qian; Richard M Ransohoff; Cornelia Bergmann; Stephen Stohlman; Vincent K Tuohy; Xiaoxia Li
Journal:  Immunity       Date:  2010-03-18       Impact factor: 31.745

9.  Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation.

Authors:  Hania Kebir; Katharina Kreymborg; Igal Ifergan; Aurore Dodelet-Devillers; Romain Cayrol; Monique Bernard; Fabrizio Giuliani; Nathalie Arbour; Burkhard Becher; Alexandre Prat
Journal:  Nat Med       Date:  2007-09-09       Impact factor: 53.440

10.  Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.

Authors:  Laura A Solt; Naresh Kumar; Philippe Nuhant; Yongjun Wang; Janelle L Lauer; Jin Liu; Monica A Istrate; Theodore M Kamenecka; William R Roush; Dušica Vidović; Stephan C Schürer; Jihong Xu; Gail Wagoner; Paul D Drew; Patrick R Griffin; Thomas P Burris
Journal:  Nature       Date:  2011-04-17       Impact factor: 49.962

View more
  84 in total

Review 1.  Th17 cells in depression.

Authors:  Eléonore Beurel; Jeffrey A Lowell
Journal:  Brain Behav Immun       Date:  2017-08-03       Impact factor: 7.217

Review 2.  The Bidirectional Relationship of Depression and Inflammation: Double Trouble.

Authors:  Eléonore Beurel; Marisa Toups; Charles B Nemeroff
Journal:  Neuron       Date:  2020-06-17       Impact factor: 17.173

Review 3.  The molecular and cellular mechanisms of depression: a focus on reward circuitry.

Authors:  Megan E Fox; Mary Kay Lobo
Journal:  Mol Psychiatry       Date:  2019-04-09       Impact factor: 15.992

Review 4.  The role of Th17 cells in the pathophysiology of pregnancy and perinatal mood and anxiety disorders.

Authors:  Lauren M Osborne; Amitoj Brar; Sabra L Klein
Journal:  Brain Behav Immun       Date:  2018-11-19       Impact factor: 7.217

5.  Lymphocytes from chronically stressed mice confer antidepressant-like effects to naive mice.

Authors:  Rebecca A Brachman; Michael L Lehmann; Dragan Maric; Miles Herkenham
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

6.  CD8+ T cells promote cytokine responses to stress.

Authors:  Sarah M Clark; Chang Song; Xin Li; Achsah D Keegan; Leonardo H Tonelli
Journal:  Cytokine       Date:  2018-07-19       Impact factor: 3.861

7.  Identification of a Signaling Mechanism by Which the Microbiome Regulates Th17 Cell-Mediated Depressive-Like Behaviors in Mice.

Authors:  Eva M Medina-Rodriguez; Derik Madorma; Gregory O'Connor; Brittany L Mason; Dongmei Han; Sapna K Deo; Mark Oppenheimer; Charles B Nemeroff; Madhukar H Trivedi; Sylvia Daunert; Eléonore Beurel
Journal:  Am J Psychiatry       Date:  2020-07-31       Impact factor: 18.112

8.  Immune status influences fear and anxiety responses in mice after acute stress exposure.

Authors:  Sarah M Clark; Joseph Sand; T Chase Francis; Anitha Nagaraju; Kerry C Michael; Achsah D Keegan; Alexander Kusnecov; Todd D Gould; Leonardo H Tonelli
Journal:  Brain Behav Immun       Date:  2014-02-10       Impact factor: 7.217

Review 9.  Regulation of inflammation and T cells by glycogen synthase kinase-3: links to mood disorders.

Authors:  Eleonore Beurel
Journal:  Neuroimmunomodulation       Date:  2014-02-14       Impact factor: 2.492

10.  (+)-Naloxone blocks Toll-like receptor 4 to ameliorate deleterious effects of stress on male mouse behaviors.

Authors:  Eva M Medina-Rodriguez; Kenner C Rice; Eléonore Beurel; Richard S Jope
Journal:  Brain Behav Immun       Date:  2020-08-26       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.